FDA Watch: Agency Takes Steps to Downgrade Some Nucleic Acid-Based Tests to Class II
The change is expected to dramatically cut the costs of developing new tests
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Genetic Testing Kickback Scheme Results in 46-Month Prison Term
Federal prosecutors continue to target situations where third-party recruiters influence test ordering
Dx Deals: Labs Exploring Cryptocurrency Share Their Plans
Know Labs and ProPhase Laboratories discussed plans that in part involve digital currencies
Bio-Reference Earnings Slowed Little by Winter
...
Already a member? Log in here
Quest, Memorial Sloan-Kettering Collaborate on Oncology Research
...
Already a member? Log in here
Cleveland HeartLab Issues Economic Benefit Study for Its Inflammation Test
...
Already a member? Log in here
Industry Buzz: NeoGenomics Revises Guidance Upward on Strong Sales
...
Already a member? Log in here
Inside the Lab Industry: Addressing the Coming Pathology Shortage
...
Already a member? Log in here
Aurora Makes Two Pathology Acquisitions to Help Boost Growth
...
Already a member? Log in here
Ameritox Wins $14.8 million Verdict Against Millennium Laboratories
...
Already a member? Log in here
AACC Pushes Back on New York Blood Glucose Regulation
...
Already a member? Log in here
Quest Invests in Two Logistics Centers
...
Already a member? Log in here